Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 HIV therapeutics.

× No keyword cloud information.

16 in total

Review 1. Development of topical microbicides to prevent the sexual transmission of HIV.

Authors: Robert W Buckheit; Karen M Watson; Kathleen M Morrow; Anthony S Ham
Journal: Antiviral Res Date: 2009-10-27 Impact factor: 5.970

2. Comparison of costs of strategies for measuring levels of human immunodeficiency virus type 1 RNA in plasma by using Amplicor and Ultra Direct assays.

Authors: J M Raboud; E Seminari; S L Rae; P R Harrigan; R S Hogg; B Conway; C Sherlock; M T Schechter; M V O'Shaughnessy; J S Montaner
Journal: J Clin Microbiol Date: 1998-11 Impact factor: 5.948

3. Ethical challenges posed by clinical progress in AIDS.

Authors: R Bayer; J Stryker
Journal: Am J Public Health Date: 1997-10 Impact factor: 9.308

4. Saquinavir-mediated inhibition of human immunodeficiency virus (HIV) infection in SCID mice implanted with human fetal thymus and liver tissue: an in vivo model for evaluating the effect of drug therapy on HIV infection in lymphoid tissues.

Authors: M Pettoello-Mantovani; T R Kollmann; C Raker; A Kim; S Yurasov; R Tudor; H Wiltshire; H Goldstein
Journal: Antimicrob Agents Chemother Date: 1997-09 Impact factor: 5.191

Review 5. Designing and developing suppository formulations for anti-HIV drug delivery.

Authors: Anthony S Ham; Robert W Buckheit
Journal: Ther Deliv Date: 2017-08

6. Frequency and determinants of use of antiretroviral and prophylactic therapies against Pneumocystis carinii Pneumonia (PCP) before AIDS diagnosis in Italy.

Authors: P A Napoli; M Dorrucci; D Serraino; P Pezzotti; S Franceschi; S Vella; G Rezza
Journal: Eur J Epidemiol Date: 1998-01 Impact factor: 8.082

Review 7. HIV in the CNS: pathogenic relationships to systemic HIV disease and other CNS diseases.

Authors: D M Rausch; M R Davis
Journal: J Neurovirol Date: 2001-04 Impact factor: 2.643

8. Modulation of human immunodeficiency virus (HIV)-specific immune response by using efavirenz, nelfinavir, and stavudine in a rescue therapy regimen for HIV-infected, drug-experienced patients.

Authors: Daria Trabattoni; Sergio Lo Caputo; Mara Biasin; Elena Seminari; Massimo Di Pietro; Giovanni Ravasi; Francesco Mazzotta; Renato Maserati; Mario Clerici
Journal: Clin Diagn Lab Immunol Date: 2002-09

9. An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses.

Authors: P André; M Groettrup; P Klenerman; R de Giuli; B L Booth; V Cerundolo; M Bonneville; F Jotereau; R M Zinkernagel; V Lotteau
Journal: Proc Natl Acad Sci U S A Date: 1998-10-27 Impact factor: 11.205

10. Comparative evaluation of the inhibitory activities of a series of pyrimidinedione congeners that inhibit human immunodeficiency virus types 1 and 2.

Authors: Robert W Buckheit; Tracy L Hartman; Karen M Watson; Sun-Gan Chung; Eui-Hwan Cho
Journal: Antimicrob Agents Chemother Date: 2007-10-29 Impact factor: 5.191